The question has shifted from "is it too expensive to cover GLP-1?" to "is it too expensive not to?" As clinical data accumulates showing that GLP-1 medications reduce the incidence and severity of the most expensive chronic diseases, payers are recognizing that proactive treatment of obesity saves money compared to treating its downstream consequences
These novel medications were originally designed to treat diabetes, and now, millions more use the injections to help with weight loss
What If I Dosed MT2 and Tanned the Same Day with Minimal Darkening
If symptoms persist or worsen, consult your healthcare provider, as dose adjustment may be necessary
Another headline-making study released at the conference , which also looked at medical records involving roughly 110,000 female patients, found those who took GLP-1s were up to 35 per cent less likely to develop breast cancer than those who didn't take the drug
Analytical standards applicable to research-compound quality and pricing comparison
